Press Release

Helicobacter Pylori Diagnostics Market to Grow with a CAGR of 4.25% through 2028

Rising prevalence of helicobacter pylori infections and increased awareness and screening programs are factors driving the Global Helicobacter Pylori Diagnostics Market in the forecast period 2024-2028.

 

According to TechSci Research report, “Helicobacter Pylori Diagnostics Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Helicobacter Pylori Diagnostics Market stood at USD 531.52 Million in 2022 and is anticipated to grow with a CAGR of 4.25% in the forecast period, 2024-2028. The global Helicobacter Pylori (H. pylori) diagnostics market has witnessed remarkable growth in recent years. H. pylori is a bacterium that infects the stomach lining and is a significant cause of various gastrointestinal disorders, including gastritis, peptic ulcers, and even stomach cancer. The diagnosis and management of H. pylori infections have become increasingly vital in the field of healthcare. One of the primary drivers of the H. pylori diagnostics market is the increasing prevalence of H. pylori infections globally. According to the World Gastroenterology Organization, around 50% of the world's population is estimated to be infected with H. pylori. This high prevalence has led to an upsurge in the demand for accurate diagnostic tests to identify and manage these infections, driving market growth. Advancements in diagnostic technologies have played a pivotal role in driving the H. pylori diagnostics market. Traditional methods for diagnosing H. pylori, such as endoscopy and biopsy, are invasive and costly. However, modern diagnostic tools, including serology tests, urea breath tests, and molecular diagnostics, offer non-invasive and more cost-effective alternatives. These technological advancements have made diagnosis more accessible, leading to increased demand for testing, thereby boosting the market.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Helicobacter Pylori Diagnostics Market.”

 

Growing awareness about the health risks associated with H. pylori infections has led to an increase in screening and diagnostic programs. Healthcare organizations and government bodies in many countries are focusing on early detection and treatment of H. pylori infections to reduce the incidence of associated diseases. As a result, there is a surge in the number of diagnostic tests performed, contributing to market growth.

H. pylori infections are closely associated with a range of gastrointestinal diseases, including gastritis, peptic ulcers, and gastric cancer. The rising incidence of these diseases, often attributed to H. pylori, is driving the demand for diagnostic tests. Healthcare providers are increasingly emphasizing the need for accurate and early diagnosis to better manage and treat these conditions, further propelling market growth. Innovations in the field of H. pylori diagnostics continue to drive market expansion. Research and development efforts are leading to the introduction of more accurate and efficient diagnostic methods. Manufacturers are investing in the development of new diagnostic devices, tests, and software solutions, improving the overall accuracy and convenience of H. pylori diagnostics.

The Global Helicobacter Pylori Diagnostics Market is segmented into type, technology, end user and company.

Based on end user, the Hospitals & Clinics segment has emerged as the predominant market leader. Hospitals and clinics are equipped with state-of-the-art diagnostic tools, including endoscopy, serological tests, and molecular diagnostics. These resources enable healthcare professionals to accurately detect H. pylori infection and related conditions. Hospitals and clinics often offer endoscopic examinations, which allow for direct visualization of the stomach lining and biopsy sampling, resulting in precise H. pylori detection. This method not only detects infection but also assesses the extent of tissue damage, offering vital information for treatment planning.

Based on region, North America segment is expected to grow during the forecast period.  The United States and Canada have been at the forefront of H. pylori research and development. Their commitment to advancing medical knowledge and improving diagnostic methods has been instrumental in driving the growth of the diagnostics market. Academic institutions, research organizations, and biotechnology companies in North America have been actively involved in developing new diagnostic technologies and treatments for H. pylori infections. This culture of innovation has led to a continuous stream of groundbreaking research, ensuring that the region remains at the forefront of diagnostic advancements.

The Asia Pacific region is experiencing rapid market growth. The lucrative nature of the H. pylori diagnostics market has attracted substantial investments in Asia Pacific. Private companies and investors are pouring resources into the development, marketing, and distribution of diagnostic products. The fierce competition within the region has driven innovation and lowered the cost of diagnostic tests, ultimately benefiting patients.

 

Major companies operating in Global Helicobacter Pylori Diagnostics Market are:

  • Thermo Fisher Scientific inc.
  • Biohit Oyj
  • Quest Diagnostics Incorporated
  • Meridian Bioscience
  • Bio-Rad Laboratories
  • Alpha Laboratories Ltd
  • F. Hoffmann-La Roche Ltd
  • Coris BioConcept
  • Certest Biotec
  • Epitope Diagnostics, Inc.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The global Helicobacter Pylori diagnostics market is experiencing significant growth due to a combination of factors, including the rising prevalence of H. pylori infections, technological advancements, increased awareness, growing incidence of associated diseases, research and development efforts, expanding healthcare infrastructure, and the demand for point-of-care testing. As healthcare systems continue to evolve and emphasize early diagnosis and effective management of helicobacter pylori infections, the market is poised for further expansion in the years to come. This growth is not only beneficial for diagnostic manufacturers but also for the overall health and well-being of individuals at risk of helicobacter pylori-related diseases.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Helicobacter Pylori Diagnostics Market By Type (Instruments, Reagents, Services), By Technology (Immunoassays, POC, Molecular Diagnostics), By End user (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Helicobacter Pylori Diagnostics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Helicobacter Pylori Diagnostics Market.

 

Contact Us-

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602

Email: [email protected]

Website: www.techsciresearch.com

Relevant Reports

Helicobacter Pylori Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Instruments, Reagents, Services), By Technology (Immunoassays, POC, Molecular Diagnostics), By End user (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition

Healthcare | Jan, 2024

Rising prevalence of helicobacter pylori infections and increased awareness and screening programs are factors driving the Global Helicobacter Pylori Diagnostics Market in the forecast period 2024-2028.

Relevant News